Operating Income (Loss) in USD of GeneDx Holdings Corp. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
GeneDx Holdings Corp. quarterly/annual Operating Income (Loss) history and change rate from 2019 to Q3 2025.
  • GeneDx Holdings Corp. Operating Income (Loss) for the quarter ending September 30, 2025 was -$3.25M, a 58.2% increase year-over-year.
  • GeneDx Holdings Corp. Operating Income (Loss) for the twelve months ending September 30, 2025 was $9.96M.
  • GeneDx Holdings Corp. annual Operating Income (Loss) for 2024 was -$23.2M, a 87.1% increase from 2023.
  • GeneDx Holdings Corp. annual Operating Income (Loss) for 2023 was -$181M, a 73% increase from 2022.
  • GeneDx Holdings Corp. annual Operating Income (Loss) for 2022 was -$668M, a 49.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

GeneDx Holdings Corp. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $9.96M -$3.25M +$4.53M +58.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 $5.44M $8.96M +$19.5M Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-29
Q1 2025 -$14.1M -$4.55M +$9.11M +66.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-30
Q4 2024 -$23.2M $8.81M +$34.4M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-20
Q3 2024 -$57.7M -$7.78M +$35.2M +81.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 -$92.8M -$10.6M +$41M +79.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-29
Q1 2024 -$134M -$13.7M +$46.7M +77.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q4 2023 -$181M -$25.6M +$299M +92.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-20
Q3 2023 -$480M -$43M +$47.8M +52.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$528M -$51.6M +$111M +68.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 -$639M -$60.4M +$28.9M +32.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 -$668M -$325M -$209M -181% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 -$459M -$90.8M -$2.55M -2.89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$456M -$163M -$117M -258% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$339M -$89.3M +$107M +54.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$446M -$116M +$9.27M +7.41% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 -$455M -$88.3M -$32.2M -57.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$423M -$45.4M -$11.3M -33% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$412M -$197M -$170M -635% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$242M -$125M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$56M Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 -$34.2M Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 -$26.8M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14

GeneDx Holdings Corp. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$23.2M +$157M +87.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-20
2023 -$181M +$487M +73% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-20
2022 -$668M -$222M -49.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 -$446M -$204M -84.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$242M -$212M -696% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 -$30.4M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.